| Systematic (IUPAC) name | |
|---|---|
| O5-methyl O3-[(3R)-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 105979-17-7 |
| ATC code | C08CA15 |
| PubChem | CID 656668 |
| ChemSpider | 571013 |
| UNII | 4G9T91JS7E |
| Chemical data | |
| Formula | C28H31N3O6 |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Benidipine (INN), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension).
Benidipine is dosed as 2–4 mg once daily.[1]
Benidipine is sold as Coniel by Kyowa Hakko Kogyo.
Benidipine is only licensed for use in Japan and selected Southeast Asian countries, where it is sold as 4 mg tablets.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)